(Q38240639)

English

Rhabdomyolysis as a clinical manifestation of association with ciprofibrate, sirolimus, cyclosporine, and pegylated interferon-α in liver-transplanted patients: a case report and literature review

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Rhabdomyolysis as a clinical manifestation of association with ciprofibrate, sirolimus, cyclosporine, and pegylated interferon-α in liver-transplanted patients: a case report and literature review (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A G dos Santos

1

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

A C Guardia

2

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

T S Pereira

3

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

E C Ataíde

4

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

M d F T Mei

5

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

M E Udo

6

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

I F S F Boin

7

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

R S B Stucchi

8

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

language of work or name

0 references

publication date

1 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

1887-1888

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Sirolimus as rescue therapy after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Rhabdomyolysis and acute kidney injury secondary to concomitant use of fluvastatin and rapamycin in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Rhabdomyolysis after concomitant use of cyclosporine and simvastatin in a patient transplanted for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Rhabdomyolysis after treatment with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: a first report

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Fenofibrate-induced acute renal failure due to massive rhabdomyolysis after coadministration of statin in two patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Clinical pharmacokinetics of fibric acid derivatives (fibrates).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Comparative effects of fibrates on drug metabolizing enzymes in human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2014.05.065

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2014.05.065

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38240639&oldid=1748989111"